Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1214385-51-9 | MDL No. : | MFCD13185807 |
Formula : | C6H4BrNO3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | YVVISLCKIQNUDL-UHFFFAOYSA-N |
M.W : | 218.00 g/mol | Pubchem ID : | 66570682 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 40.92 |
TPSA : | 70.42 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.65 cm/s |
Log Po/w (iLOGP) : | 0.97 |
Log Po/w (XLOGP3) : | 1.38 |
Log Po/w (WLOGP) : | 1.25 |
Log Po/w (MLOGP) : | -0.52 |
Log Po/w (SILICOS-IT) : | 0.96 |
Consensus Log Po/w : | 0.81 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -2.4 |
Solubility : | 0.871 mg/ml ; 0.00399 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.46 |
Solubility : | 0.752 mg/ml ; 0.00345 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -1.68 |
Solubility : | 4.52 mg/ml ; 0.0207 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.6 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
99% | at 80℃; for 16 h; | Bromine (115 g, 720 mmol) was added drop-wise to a suspension of 6-oxo-1,6-dihydropyridine-2-carboxylic acid (25 g, 180 mmol) in acetic acid (400 mL). The reaction mixture was heated to 80° C. for 16 hours, whereupon it was concentrated to dryness under reduced pressure. The residue was triturated with tert-butyl methyl ether (200 mL) and filtered; the filter cake was washed with tert-butyl methyl ether (3×100 mL) to provide the product as a gray solid. Yield: 39.0 g, 179 mmol, 99percent. 1H NMR (400 MHz, DMSO-d6) δ 8.03 (d, J=7.3 Hz, 1H), 6.83 (d, J=7.3 Hz, 1H). |
[ 1214334-70-9 ]
5-Bromo-6-methoxypicolinic acid
Similarity: 0.93
[ 1214346-74-3 ]
Ethyl 5-bromo-6-hydroxypicolinate
Similarity: 0.90
[ 1214329-07-3 ]
Methyl 5-bromo-6-methoxypicolinate
Similarity: 0.88
[ 886365-02-2 ]
5-Bromo-4-methylpyridine-2-carboxylic acid
Similarity: 0.80
[ 1214346-74-3 ]
Ethyl 5-bromo-6-hydroxypicolinate
Similarity: 0.90
[ 115185-81-4 ]
6-Hydroxy-3-methylpicolinic acid
Similarity: 0.77
[ 1260883-63-3 ]
Methyl 5,6-dihydroxypicolinate
Similarity: 0.71
[ 39977-41-8 ]
5-(Hydroxymethyl)picolinic acid
Similarity: 0.69
[ 1214334-70-9 ]
5-Bromo-6-methoxypicolinic acid
Similarity: 0.93
[ 886365-02-2 ]
5-Bromo-4-methylpyridine-2-carboxylic acid
Similarity: 0.80
[ 886365-43-1 ]
5-Bromo-3-methylpicolinic acid
Similarity: 0.79
[ 115185-81-4 ]
6-Hydroxy-3-methylpicolinic acid
Similarity: 0.77
[ 1214334-70-9 ]
5-Bromo-6-methoxypicolinic acid
Similarity: 0.93
[ 1214346-74-3 ]
Ethyl 5-bromo-6-hydroxypicolinate
Similarity: 0.90
[ 1214329-07-3 ]
Methyl 5-bromo-6-methoxypicolinate
Similarity: 0.88
[ 886365-02-2 ]
5-Bromo-4-methylpyridine-2-carboxylic acid
Similarity: 0.80